Why the study?
Do SAPS II and SAPS 3 scores accurately predict in-hospital mortality in patients admitted to an intermediate care unit?
Do SAPS II and SAPS 3 scores accurately predict in-hospital mortality in patients admitted to an intermediate care unit?
Both SAPS II and SAPS 3 scores overpredict mortality in intermediate care patients, though SAPS II demonstrates slightly better performance in terms of standardized mortality ratio.
Both SAPS II and SAPS 3 overpredict mortality in intermediate care; leaves open need for recalibration and prospective validation.
OBJECTIVE: The efficacy and reliability of prognostic scores has been described extensively for intensive care, but their role for predicting mortality in intermediate care patients is uncertain. To provide more information in this field, we have analyzed the performance of the Simplified Acute Physiology Score (SAPS) II and SAPS 3 in a single center intermediate care unit (ImCU). MATERIALS AND METHODS: Cohort study with prospectively collected data from all patients admitted to a single center ImCU in Pamplona, Spain, from April 2006 to April 2012. The SAPS II and SAPS 3 scores with respective predicted mortality rates were calculated according to standard coefficients. Discrimination was evaluated by calculating the area under receiver operating characteristic curve (AUROC) and calibration with the Hosmer-Lemeshow goodness of fit test. Standardized mortality ratios (SMR) with 95% confidence interval (95% CI) were calculated for each model. RESULTS: The study included 607 patients. The observed in-hospital mortality was 20.1% resulting in a SMR of 0.87 (95% CI 0.73-1.04) for SAPS II and 0.56 (95% CI 0.47-0.67) for SAPS 3. Both scores showed acceptable discrimination, with an AUROC of 0.76 (95% CI 0.71-0.80) for SAPS II and 0.75 (95% CI 0.71- 0.80) for SAPS 3. Calibration curves showed similar performance based on Hosmer-Lemeshow goodness of fit C-test: (X(2)=12.9, p=0.113) for SAPS II and (X(2)=4.07, p=0.851) for SAPS 3. CONCLUSIONS: Although both scores overpredicted mortality, SAPS II showed better discrimination for patients admitted to ImCU in terms of SMR.
No takes yet. Share an insight, caveat, or question.
Lucena et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: